Pfizer and BioNTech modify COVID-19 vaccine delivery schedule with European Commission
Pfizer and BioNTech have agreed with the European Commission to amend their COVID-19 vaccine delivery schedules. Deliveries planned for June-August 2022 will now occur from September through the fourth quarter.
Pfizer Inc. and BioNTech SE announced an agreement with the European Commission to amend their previously established delivery schedules for the Pfizer-BioNTech COVID-19 Vaccine. This adjustment will rephase planned deliveries originally slated for June through August 2022 to September through the fourth quarter of 2022.
The amendment is intended to support the ongoing immunization programs of the European Commission and its member states, aligning with the companies' commitment to practical solutions for evolving pandemic needs. Pfizer and BioNTech stated that this change in schedule will not impact their full-year 2022 revenue guidance or their commitment to deliver the total agreed-upon number of doses to EU member states in 2022.
In parallel, Pfizer and BioNTech continue their evaluation of potential adapted and variant-based vaccines. The companies expect to share data from these ongoing studies in the coming months. Further details regarding the specific reasons for the delivery rephasing were not immediately provided.